// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Aspirin is equivalent to dual antiplatelet therapy after transcatheter aortic valve replacement: a meta-analysis of 11,781 patients

Yousif Ahmad - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

Aspirin

Pressure-Controlled Intermittent Coronary Sinus Occlusion Reduces Infarct Size After primary PCI: A propensity-controlled matched study

MOHANED EGRED - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetes

N/A

First Experience with the Coronary Sinus Reducer System for the Management of Refractory Angina in Patients Without Obstructive Coronary Artery Disease

Francesco Giannini - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Strut thickness impact on thrombogenicity in BRS: In-vitro insights

Shengjie Lu - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Everolimus

Impact of Pre-existent Prosthesis-Patient Mismatch on Survival Following Aortic Valve-in-Valve Procedures

Matheus Simonato dos Santos - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Patient prosthesis mismatch

N/A

Surgical Bioprosthesis Size Definition and Hemodynamic Performance following Aortic Valve-in-Valve: Insights from the Valve-in-Valve International Data (VIVID) Registry

Massimo Napodano - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Diagnostic Accuracy of Coronary Computed Tomography Angiography for the Evaluation of Bioresorbable Vascular Scaffolds

Carlos Collet - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Everolimus

Everolimus-Eluting Stents versus Coronary Artery Bypass Graft Surgery for Left Main Coronary Artery Disease in Patients with and without Chronic Kidney Disease

Gennaro Giustino - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Left main disease

Everolimus

Impact of Chronic Obstructive Pulmonary Disease in Patients with Left Main Disease Randomized to PCI vs. CABG: A Propensity Score Matched Analysis From the EXCEL Trial

Xin Huang - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

Everolimus

Outcomes of Left Main PCI vs CABG According the Number of Diseased Coronary Arteries: The EXCEL trial

Erick Schampaert - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Coronary Artery Disease

Everolimus

Outcomes Following Left Main PCI vs. CABG in Patients With Cerebrovascular Disease: Results From the EXCEL Trial

Jamie Diamond - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Carotid artery stenosis

Everolimus

Outcomes of Radial Compared with Femoral Artery Access in Patients Undergoing PCI for Left Main Disease: Analysis from the EXCEL Trial

Shmuel Chen - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Left main disease

Everolimus

Minimizing the Sham Effect to Optimize Hypertension Studies: Analyses from the Wave IV study

Melvin Lobo - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertension

N/A

Assessment of the non-culprit lesion in patients with STEMI: a comparison between FFR and iFR

Nina van der Hoeven - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Adenosine

Treatment Recommendations Based on SYNTAX Score II and Observed 3-year Mortality in the EXCEL Trial

Patrick Serruys - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Hydroxyzine

Intracoronary versus intravenous infusion of adenosine for the accurate assessment of fractional flow reserve: the hyperemic study

Ahmed Elghamaz - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Adenosine

Impact of right atrial pressure on fractional flow reserve calculation in the presence of a chronic total occlusion

Grigoris Karamasis - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Chronic total occlusion

Adenosine

One-year outcomes of the hybrid CTO revascularization strategy: a sub-analysis of the multicenter RECHARGE Registr

Joren Maeremans - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Pacemaker-related complications in patients undergoing transcatheter aortic valve implantation: a single-center experience

Giuseppe Lanzillo - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Patent Foramen Ovale Closure to treat Obstructive Sleep Apnea – the PCOSA pilot study

Stephen Hoole - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Sleep apnoea

N/A

Copyright © 2026. QuantiNova All rights reserved